ISIN and CFI codes allocation

ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' requests relating to new instruments and monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
28721-28740 of 81437 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US04962H1005 ATOSSA THERAPEUTICS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US04962H2094 ATOSSA THERAPEUTICS INC; US COM NEW ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US04962H5063 ATOSSA THERAPEUTICS INC; COM PAR$ ESVUFR 2015 ANNA Free ISIN Lookup, Ïèñüìî ÍÍÀ 2025-07-14
US04962H7044 ATOSSA THERAPEUTICS INC; COM PAR $0.18 NEW ESVUFR 2015 ANNA Free ISIN Lookup, Ïèñüìî ÍÍÀ 2026-02-03
US04963C2098 ATRICURE INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US04965B1008 ATOMERA INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US04965G1094 ATRECA INC; US CL A COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US04965N1046 ATRIUM THERAPEUTICS INC; COM ESVUFR 2015 ANNA Free ISIN Lookup, Ïèñüìî ÍÍÀ 2026-03-02
US0499041053 ATRION CORP; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0500951084 ATWOOD OCEANICS INC; US COM ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0504731078 AUBURN NATL BANCORP; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US05069A3023 AUDIBLE INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US05070J1025 AUDIENCE INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US05070N1037 AUDACY INC; US CL A ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-07-01
US05070N2027 AUDACY INC; US CL A NEW ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2023-07-09
US05070R1041 AUDENTES THERAPEUTICS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-10-16
US05072K1079 AUDDIA INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US0507342014 AUDIOEYE INC; US COM NEW ESVXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0507571034 AUDIOVOX CORP; US CL A ESXXXX 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US05105P1075 ; ESVUFR 2001 ïèñüìî HHA Ïèñüìî ÍÍÀ 2021-11-29

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version